Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ortho-ATI for rotator cuff tendinopathy and partial intrasubstance supraspinatus tear
ACTRN12617000684325Phase 2Completed
- Sponsor
- Orthocell
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in shoulder tendinopathy and rotator cuff tear comparing Ortho-ATI with Celestone Chronodose comparator (2 arms). Started Jul 2017; status: completed.
02
Drugs
autologous tenocytesbetamethasone sodium
03
Conditions
shoulder tendinopathyrotator cuff tear
Beyond the preview
Go deeper on ACTRN12617000684325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000684325.